Literature DB >> 30158559

FDA approves patisiran to treat hereditary transthyretin amyloidosis.

Heather Wood1.   

Abstract

Entities:  

Year:  2018        PMID: 30158559     DOI: 10.1038/s41582-018-0065-0

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  36 in total

Review 1.  Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9.

Authors:  Hong-Xia Zhang; Ying Zhang; Hao Yin
Journal:  Mol Ther       Date:  2019-01-25       Impact factor: 11.454

Review 2.  Applications of RNA interference in the treatment of arthritis.

Authors:  Muhammad Farooq Rai; Hua Pan; Huimin Yan; Linda J Sandell; Christine T N Pham; Samuel A Wickline
Journal:  Transl Res       Date:  2019-07-10       Impact factor: 7.012

3.  Dual inhibition of endothelial miR-92a-3p and miR-489-3p reduces renal injury-associated atherosclerosis.

Authors:  Carrie B Wiese; Jianyong Zhong; Zhi-Qi Xu; Youmin Zhang; Marisol A Ramirez Solano; Wanying Zhu; MacRae F Linton; Quanhu Sheng; Valentina Kon; Kasey C Vickers
Journal:  Atherosclerosis       Date:  2019-01-30       Impact factor: 5.162

Review 4.  Disease-modifying therapy for proteinopathies: Can the exception become the rule?

Authors:  Gal Bitan
Journal:  Prog Mol Biol Transl Sci       Date:  2019-08-07       Impact factor: 3.622

5.  Integrating Combinatorial Lipid Nanoparticle and Chemically Modified Protein for Intracellular Delivery and Genome Editing.

Authors:  Jin Chang; Xianghan Chen; Zachary Glass; Feng Gao; Lanqun Mao; Ming Wang; Qiaobing Xu
Journal:  Acc Chem Res       Date:  2018-12-26       Impact factor: 22.384

Review 6.  RNA therapy: Are we using the right molecules?

Authors:  Ai-Ming Yu; Chao Jian; Allan H Yu; Mei-Juan Tu
Journal:  Pharmacol Ther       Date:  2018-12-04       Impact factor: 12.310

Review 7.  Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.

Authors:  Angelos G Rigopoulos; Muhammad Ali; Elena Abate; Abdel-Rahman Torky; Marios Matiakis; Mammad Mammadov; Hannes Melnyk; Alexander Vogt; Renato de Vecchis; Boris Bigalke; Walter Wohlgemuth; Sophie Mavrogeni; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

Review 8.  RNA delivery biomaterials for the treatment of genetic and rare diseases.

Authors:  Weiyu Zhao; Xucheng Hou; Olivia G Vick; Yizhou Dong
Journal:  Biomaterials       Date:  2019-06-20       Impact factor: 12.479

9.  RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.

Authors:  Ai-Ming Yu; Young Hee Choi; Mei-Juan Tu
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

10.  Recent Progress of Polymeric Nanogels for Gene Delivery.

Authors:  Rima Kandil; Olivia M Merkel
Journal:  Curr Opin Colloid Interface Sci       Date:  2019-01-16       Impact factor: 6.448

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.